Join leading FDA,industry, and academic experts at CHI’s 18th Annual Immunogenicity & Bioassay Summit, taking place October 19–22, 2026, in Alexandria, VA + virtually.This premier summit will feature comprehensive coverage of immunogenicity risk assessment, bioassay development, clinical strategies, and regulatory expectations, including talks from 8 confirmed FDA speakers. The program also features interactive discussions, expert-led training seminars and short courses, a dynamic exhibit and poster hall, and much more.The 2026 attendee list is now live. Explore who’s attending and join us this October for theinsights andhigh-value networking opportunities you need to move your programs forward.
